Literature DB >> 8603833

Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity.

J Stone1, T Chan-Ling, J Pe'er, A Itin, H Gnessin, E Keshet.   

Abstract

PURPOSE: To assess the role of vascular endothelial growth factor (VEGF) in the feline model of retinopathy of prematurity (ROP).
METHODS: Retinopathy of prematurity was induced in neonatal cats by raising them in an oxygen-enriched (70% to 80%) atmosphere for 4 days to suppress vessel formation and then returning them to room air for 3 to 27 days. In situ hybridization was used to detect the expression of VEGF and its high-affinity receptor, flk-1, in the retina of neonatal cats, and glial fibrillary acidic protein immunocytochemistry was used to assess astrocyte status.
RESULTS: The expression of VEGF in the innermost layers of retina fell in hyperoxia and increased on return to room air. Vascular endothelial growth factor expression was transient; it was maximal where vessels were about to form, and it rapidly downregulated after vessels had formed. During the proliferative vasculopathy of ROP, VEGF expression was stronger than in the normally developing retina, and the astrocytes that normally express VEGF degenerated. After the degeneration of astrocytes, VEGF was expressed by neurones of the ganglion cell layer. flk-1 was expressed by intraretinal and preretinal vessels. Supplemental oxygen therapy reduced or eliminated the overexpression of VEGF expression, astrocyte degeneration, and formation of preretinal vessels.
CONCLUSIONS: Regulation of VEGF by tissue oxygen mediates the inhibition of vessel growth during hyperoxia and the subsequent proliferative vasculopathy. Degeneration of retinal astrocytes creates conditions for the growth of preretinal vessels.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603833

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  89 in total

1.  More weapons in the arsenal against ischemic retinopathy.

Authors:  E Keshet
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

2.  Diode laser treatment of posterior retinopathy of prematurity.

Authors:  R Axer-Siegel; M Snir; D Cotlear; A Maayan; R Frilling; I Rosenbaltt; D Weinberger; I Kremer; L Sirota
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

3.  Retinal neovascular markers in retinopathy of prematurity: aetiological implications.

Authors:  P E North; D C Anthony; T L Young; M Waner; H H Brown; M C Brodsky
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 5.  The mouse retina as an angiogenesis model.

Authors:  Andreas Stahl; Kip M Connor; Przemyslaw Sapieha; Jing Chen; Roberta J Dennison; Nathan M Krah; Molly R Seaward; Keirnan L Willett; Christopher M Aderman; Karen I Guerin; Jing Hua; Chatarina Löfqvist; Ann Hellström; Lois E H Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06       Impact factor: 4.799

Review 6.  Adenosine receptors and caffeine in retinopathy of prematurity.

Authors:  Jiang-Fan Chen; Shuya Zhang; Rong Zhou; Zhenlang Lin; Xiaohong Cai; Jing Lin; Yuqing Huo; Xiaoling Liu
Journal:  Mol Aspects Med       Date:  2017-01-11

7.  Microvascular patterning is controlled by fine-tuning the Akt signal.

Authors:  Jing Fang Sun; Thuy Phung; Ichiro Shiojima; Terri Felske; J Nalinee Upalakalin; Dian Feng; Tad Kornaga; Talia Dor; Ann M Dvorak; Kenneth Walsh; Laura E Benjamin
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-20       Impact factor: 11.205

8.  Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.

Authors:  Anupam Basu; Gina Menicucci; Joann Maestas; Arup Das; Paul McGuire
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

9.  Transforming growth factor beta1 induction of vascular endothelial growth factor receptor 1: mechanism of pericyte-induced vascular survival in vivo.

Authors:  Shu-Ching Shih; Meihua Ju; Nan Liu; Jan-Rung Mo; Joshua J Ney; Lois E H Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-03       Impact factor: 11.205

Review 10.  Oxygen supply and consumption in the retina: implications for studies of retinopathy of prematurity.

Authors:  Stephen J Cringle; Dao-Yi Yu
Journal:  Doc Ophthalmol       Date:  2009-10-15       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.